Literature DB >> 15169648

[Construction and expression of recombinant antibody/granzyme B containing truncated translocating peptide].

Li Zhang1, Jing Zhao, Zhi Wang, Wei-hong Wen, Ying-hua Zhang, Cheng-ji Wang, An-gang Yang.   

Abstract

AIM: To construct an eukaryotic expression vector for recombinant antibody/granzyme B gene containing truncated translocating peptide and express it in HER-2(+) SKBR-3 cells and HER-2(-) Hela cells.
METHODS: PCR amplication was used to obtain recombinant DNA encoding antibody/granzyme B containing truncated translocating peptide DNA, and then the DNA fragment was cloned into eukaryotic expression vector pCMV-e23sFv-PE40. After being transfected into SKBR-3 cells and Hela cells, the expression of target gene and its effect on cellular morphology were detected by immunocytochemical staining.
RESULTS: The eukaryotic expression vector encoding recombinant antibody/granzyme B containing truncated translocating peptide was successfully constructed. e23sFv-FSD-GrB protein was expressed in most of Hela cells and had no effect on Hela cells, but the transfected SKBR-3 cells which also express e23sFv-FSD-GrB protein exhibited condensed nucleus and cytoplasm.
CONCLUSION: The construction of eukaryotic expression vector of recombinant antibody/granzyme B gene containing truncated translocating peptide lays the foundation for further determination of minimal fragment responsible for translocation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15169648

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  2 in total

1.  Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B.

Authors:  Lawrence H Cheung; Yunli Zhao; Ana Alvarez-Cienfuegos; Khalid A Mohamedali; Yu J Cao; Walter N Hittelman; Michael G Rosenblum
Journal:  J Exp Clin Cancer Res       Date:  2019-07-30

Review 2.  Pseudomonas Exotoxin-Based Immunotoxins: Over Three Decades of Efforts on Targeting Cancer Cells With the Toxin.

Authors:  Seyed Mehdi Havaei; Marc G Aucoin; Ali Jahanian-Najafabadi
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.